News Website

Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer - PharmaLive

Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer PharmaLive

Published: May 18, 2026, 1:38 p.m.

Read Full Article

The Evolving Role of the Pharmacist: From Clinical Pathways to Patient Advocacy - Pharmacy Times

The Evolving Role of the Pharmacist: From Clinical Pathways to Patient Advocacy Pharmacy Times

Published: May 18, 2026, 12:19 p.m.

Read Full Article

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Business Wire

Published: May 18, 2026, 10:45 a.m.

Read Full Article

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.

Read Full Article

PCOS gets a new name after 14 years of research and patient advocacy - LEX18

PCOS gets a new name after 14 years of research and patient advocacy LEX18

Published: May 14, 2026, 10:05 a.m.

Read Full Article

PCOS gets a new name after 14 years of research and patient advocacy - LEX 18 News

PCOS gets a new name after 14 years of research and patient advocacy LEX 18 News

Published: May 13, 2026, 11:05 p.m.

Read Full Article

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)

Published: May 12, 2026, 7:56 p.m.

Read Full Article

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes The American Journal of Managed Care

Published: May 12, 2026, 7:56 p.m.

Read Full Article

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes The American Journal of Managed Care® (AJMC®)

Published: May 12, 2026, 7:52 p.m.

Read Full Article

‘I couldn’t really talk about this’: Medical system fails to recognize signs of endometriosis, patient says - CTV News

‘I couldn’t really talk about this’: Medical system fails to recognize signs of endometriosis, patient says CTV News

Published: May 12, 2026, 12:40 a.m.

Read Full Article

Latest Articles

Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer - PharmaLive

The Evolving Role of the Pharmacist: From Clinical Pathways to Patient Advocacy - Pharmacy Times

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

PCOS gets a new name after 14 years of research and patient advocacy - LEX18

PCOS gets a new name after 14 years of research and patient advocacy - LEX 18 News

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop It Have Better Survival Outcomes - The American Journal of Managed Care

Endometriosis Raises Ovarian Cancer Risk, but Patients Who Develop it Have Better Survival Outcomes - The American Journal of Managed Care® (AJMC®)

‘I couldn’t really talk about this’: Medical system fails to recognize signs of endometriosis, patient says - CTV News

Subscribe to Our Newsletter